Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.
Key Details
- 1Aidoc's new AI product can detect a variety of urgent, life-threatening conditions from CT scans.
- 2The solution operates within a single workflow, streamlining triage for radiologists.
- 3This is believed to be the first FDA Breakthrough Device designation for an AI covering such a broad scope in one tool.
- 4The FDA Breakthrough Device Program is intended to speed market access for innovative medical technologies.
Why It Matters
Breakthrough Device status can accelerate regulatory review, paving the way for faster clinical adoption of comprehensive triage AI tools. This could improve patient outcomes by expediting the detection and management of critical conditions.
Source
Radiology Business
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•AuntMinnie
AI Increases Lung Nodule Detection on LDCT but Not Speed
AI assistance raised detection rates of actionable lung nodules on LDCT but did not reduce interpretation time for radiologists.
•Radiology Business
Prospective Study Confirms AI Boosts Lung Nodule Detection in CT Screening
A new prospective trial finds AI assistance significantly increases detection of suspicious lung nodules in low-dose chest CT screenings.